Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Genetic Survey of Psilocybe Natural Products.

Dörner S, Rogge K, Fricke JiD, Schäfer T, Wurlitzer JM, Gressler MiD, Pham DNK, Manke DR, Chadeayne AR, Hoffmeister DiD

Chembiochem : a European journal of chemical biologyJun 9, 2022License: open accessGermany, United States31 citationsDOI: 10.1002/cbic.202200249

Abstract

Psilocybe magic mushrooms are best known for their main natural product, psilocybin, and its dephosphorylated congener, the psychedelic metabolite psilocin. Beyond tryptamines, the secondary metabolome of these fungi is poorly understood. The genomes of five species (P. azurescens, P. cubensis, P. cyanescens, P. mexicana, and P. serbica) were browsed to understand more profoundly common and species-specific metabolic capacities. The genomic analyses revealed a much greater and yet unexplored metabolic diversity than evident from parallel chemical analyses. P. cyanescens and P. mexicana were identified as aeruginascin producers. Lumichrome and verpacamide A were also detected as Psilocybe metabolites. The observations concerning the potential secondary metabolome of this fungal genus support pharmacological and toxicological efforts to find a rational basis for yet elusive phenomena, such as paralytic effects, attributed to consumption of some magic mushrooms.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Keywords

Kinasesmetabolomesecondary metabolismAeruginascin

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.